Alimera Sciences News

News on Alimera Sciences (Ticker: ALIM) continually updated from thousands of sources around the net.

Apr 25, 2012 | InvestorIdeas.com

Tuesday's NASDAQ Top % Gainers: IBCP, ALIM, ALGN, LNET

April 25, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday, April 24th.

Comment?

Tue Apr 24, 2012

BioSpace

Alimera Sciences Release: ILUVIEN(R) Receives Marketing Authorization ...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Alimera Sciences Release: ILUVIEN Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema ATLANTA, April 24, 2012 -- Alimera Sciences, ... (more)

Comment?

Related Topix: Marketing

Wed Apr 18, 2012

Seeking Alpha

Psivida: Small-Cap Ophthalmology-Based BioTech Positioned For Long-Term Growth

I find the following small cap company very interesting for a long term speculative buy.

Comment?

Wed Mar 28, 2012

InvestorIdeas.com

Tuesday's NASDAQ Winners: PSDV, SCMF, HOGS, ISTA

March 28, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday March 27th.

Comment?

Thu Mar 22, 2012

International Business Times

Post-Market NASDAQ Movers

The top after-market NASDAQ losers were: Sonic Corp., Herman Miller, Alimera Sciences, Inc.

Comment?